This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

What a Gamed Market

09/27/13 - 12:26 PM EDT

What I love about Jim Cramer is that he fully gets the gaming of the market. So when I saw Jim's piece yesterday, headlined, "Don't Read This Herb," I could do little more than shake my head.


Greenberg: Red Flags Flying Over Boulder Brands

09/26/13 - 06:00 AM EDT

On the surface, the growth looks impressive. But at Boulder Brands a number of red flags fly that look past its impressive growth. Will its gluten-free push roll the wrong way?


Herb Greenberg: What to Watch With Apple

09/23/13 - 12:29 PM EDT

This weekend Apple delivered a serious one-two punch to anyone who thought it was dead or dying. Will it bounce higher, lockstep with other given-up-for-dead momo names, like Netflix? Is this Apple's last hurrah or the beginning of a new phase?


BlackBerry Lands in Corporate Hospice

09/23/13 - 10:28 AM EDT

The latest spin on BlackBerry is that it will re-focus on services in a last-ditch effort to survive.


Greenberg: This Market's the Greater Fool Theory

09/18/13 - 02:06 PM EDT

Herb says, the out-of-whack valuations of cult stocks make his stomach turn.


Secondaries Flying off the Shelves -- Bullish Sign?

09/18/13 - 11:00 AM EDT

IPOs are grabbing the headlines, but the real story isn't IPOs at all -- but secondaries.


This Market Summed Up in One Stock: Blyth

09/16/13 - 02:08 PM EDT

If you want to understand the current market, look no further than one name: Blyth.


Summers and Heroin

09/16/13 - 09:22 AM EDT

This morning I tweeted: "Face it -- Market's knee-jerk reaction to Summers news is removal of the fear that someone would lock up the heroin."


Greenberg: Warning Bells at MercadoLibre

09/12/13 - 01:33 PM EDT

The CEO's recent sale may have once again top-ticked the stock.


Greenberg: Revisiting Three Much-Talked-About Names

09/10/13 - 11:19 AM EDT

Here are updates on Intuitive Surgical, Green Mountain and Herbalife.


Herb Greenberg is the editor of Herb Greenberg's Reality Check, a subscription newsletter designed to help investors better manage risk.

Greenberg has been a financial journalist for more than 30 years, working most recently as a senior stocks commentator on CNBC's business day programming and on He was also co-president of Greenberg Meritz Research & Analytics. He is a former weekend investor columnist for The Wall Street Journal and a former senior columnist for MarketWatch.

Expand Bio +

Prior to joining MarketWatch, Greenberg was senior columnist forTheStreet. He previously spent 10 years as the "Business Insider" columnist for the San Francisco Chronicle and nearly seven years asFortune magazine's monthly "Against the Grain" columnist. Before that, he was the New York financial correspondent for the Chicago Tribune and a financial reporter in its Chicago newsroom. Greenberg has held various positions at other media outlets including Crain's Chicago Business and the St. Paul Pioneer Press.

Close Bio -


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Herb's Tweets

Brokerage Partners

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs